Heinonen P K, Kallioniemi O P, Koivula T
Tumori. 1987 Jun 30;73(3):301-2. doi: 10.1177/030089168707300315.
The serum concentrations of CA 125 and placental alkaline phosphatase were analyzed in 16 patients with ovarian cancer. Increased serum levels of CA 125 and placental alkaline phosphatase were observed in 75% and 50% of the cancer patients, respectively. The serum levels of these tumor markers were not correlated, supporting their distinct antigenic nature. CA 125 seems to be a more promising tumor marker for ovarian cancer than placental alkaline phosphatase.
对16例卵巢癌患者的血清CA 125和胎盘碱性磷酸酶浓度进行了分析。分别在75%和50%的癌症患者中观察到血清CA 125和胎盘碱性磷酸酶水平升高。这些肿瘤标志物的血清水平不相关，支持了它们不同的抗原性质。与胎盘碱性磷酸酶相比，CA 125似乎是一种更有前景的卵巢癌肿瘤标志物。
